PRESS RELEASE published on 06/03/2025 at 12:10, 1 year 1 month ago Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth Lobe Sciences Ltd. appoints Mr. Yong Yao as CFO & EVP, leveraging his 25 years of finance & biotech experience to drive financial strategy & growth. Strategic shift to full-time financial leadership Chief Financial Officer Executive Vice President Finance Strategy Lobe Sciences Yong Yao
BRIEF published on 04/14/2025 at 13:05, 1 year 3 months ago Lobe Sciences lance un placement privé pour le développement de médicaments Placement Privé Essais Cliniques Sciences Du Lobe Cynaptec Pharmaceuticals Psilocine Conjuguée
BRIEF published on 04/14/2025 at 13:05, 1 year 3 months ago Lobe Sciences Initiates Private Placement for Drug Development Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
PRESS RELEASE published on 04/14/2025 at 13:00, 1 year 3 months ago Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM) Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec
BRIEF published on 04/05/2025 at 05:55, 1 year 3 months ago Lobe Sciences Provides Corporate Update on Recent Transactions Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
BRIEF published on 04/05/2025 at 05:55, 1 year 3 months ago Lobe Sciences fournit une mise à jour de l'entreprise sur les transactions récentes Essais Cliniques Billets Convertibles Commentaires De La FDA Sciences Du Lobe Mucate De Psilocine
PRESS RELEASE published on 04/05/2025 at 05:50, 1 year 3 months ago Lobe Sciences Provides Corporate Update Lobe Sciences provides corporate update on recent transactions and business progress including patents and clinical study results. Focus on lipid technology solutions for medical needs Corporate Update Recent Transactions Lobe Sciences Lipid Technology Medical Needs
Published on 07/25/2026 at 00:35, 1 day 23 hours ago Pathfinder Ventures Inc. Provides Corporate Update
Published on 07/24/2026 at 23:00, 2 days ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 2 days 1 hour ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 2 days 1 hour ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 2 days 3 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/26/2026 at 19:12, 4 hours 34 minutes ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/26/2026 at 18:46, 5 hours ago EQS-Adhoc: Kapsch TrafficCom reaches agreement with its major financial creditors on key terms of a restructuring.
Published on 07/24/2026 at 18:44, 2 days 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:50, 2 days 4 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 2 days 4 hours ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 2 days 5 hours ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group